Skip to content
PubMed This is a summary of 19 peer-reviewed journal articles Updated
Hematology · Acquired Hemophilia A

Can You Get Hemophilia A Later in Life? What to Know

At a Glance

Yes. A rare condition called acquired hemophilia A can develop later in life when the immune system blocks factor VIII, causing sudden bleeding and large bruises. It requires urgent medical evaluation, blood testing, bleeding control, and treatment to remove the inhibitor.

Yes, it is possible to develop a form of hemophilia later in life, even if you were not born with it. While classic congenital Hemophilia A is a genetic condition you inherit, there is a rare, distinct condition called Acquired Hemophilia A (AHA) [1][2].

Acquired Hemophilia A is an autoimmune disorder. This means your immune system mistakenly produces antibodies (called inhibitors) that attack and neutralize your body’s own clotting factor VIII [1]. Because your factor VIII no longer works normally, your blood loses its ability to clot properly, leading to unexpected and often severe bleeding [3].

When to Seek Immediate Emergency Care

Because Acquired Hemophilia A can cause life-threatening internal bleeding, it is considered a medical emergency [4]. Do not wait to see if symptoms improve. Seek immediate emergency medical care if you experience:

  • Rapidly enlarging, painful bruises or hematomas (firm pools of blood under the skin)
  • Blood in your urine or stool (including black, tarry stools)
  • Vomiting or coughing up blood
  • Severe headache, confusion, or severe weakness
  • Sudden, severe back or abdominal pain
  • Shortness of breath
  • Any bleeding that will not stop

Important precautions: While awaiting or undergoing treatment, do not take aspirin, ibuprofen, naproxen, or other NSAIDs unless specifically instructed by your hematologist, as these increase bleeding risk. Avoid intramuscular injections, tell all healthcare providers and dentists about your condition, and consider wearing a medical alert bracelet.

How Acquired Hemophilia A Differs from Classic Hemophilia

Although both conditions involve a shortage of factor VIII, they affect different people and present differently:

  • Who gets it: Genetic hemophilia A is present from birth, though mild cases are sometimes only discovered later in life after surgery or trauma [5]. Acquired hemophilia A affects men and women equally, and typically appears in older adults [6]. It can also develop in younger women during pregnancy or, more commonly, one to four months after childbirth [7].
  • Underlying associations: About half of acquired hemophilia cases happen for no known reason (idiopathic) [8][9]. The other half are associated with underlying health conditions, such as other autoimmune diseases, pregnancy, or certain cancers [10][9]. Finding an association does not automatically mean you have cancer; your doctor will use your history and age-appropriate screenings to guide the evaluation.
  • Bleeding patterns: Moderate or severe genetic hemophilia A frequently causes deep bleeding inside the joints, such as the knees or elbows [11][12]. In contrast, acquired hemophilia A typically causes sudden, severe bleeding into the skin (producing massive bruises), muscles, or mucous membranes [13][14][12].

How is it Diagnosed?

Acquired Hemophilia A is usually suspected when someone with no personal or family history of bleeding problems suddenly develops large, unexplained bruises or severe bleeding [13][14].

A routine blood test may show an isolated prolonged aPTT (a measure of how long it takes blood to clot) [4][15]. A prolonged aPTT is just a clue, not a confirmation. To officially diagnose AHA and rule out other issues (like medication side effects or previously unrecognized mild genetic hemophilia), doctors will run specific blood tests. These include checking your actual factor VIII activity levels, performing a “mixing study,” and running an inhibitor assay (such as the Bethesda test) to confirm the presence of the autoimmune antibodies [16][17].

How is it Treated?

Treatment requires specialized care from a hematologist and focuses on two main goals:

1. Stopping the bleeding
Standard human factor VIII replacement therapies are often quickly neutralized by the body’s antibodies. Instead, doctors typically use specialized medications to stop active bleeds [4][16]. These may include bypassing agents (medicines that activate clotting downstream of factor VIII) or recombinant porcine factor VIII (a laboratory-produced medicine based on the pig factor VIII sequence) [4][16][18]. The choice depends on your specific inhibitor levels, bleeding severity, and clotting risks.

2. Eradicating the inhibitor
To induce remission, doctors use immune-suppressing medications to stop your immune system from attacking factor VIII [16][4]. These medications—which may include corticosteroids, rituximab, or cyclophosphamide—are highly individualized based on your age, overall health, and inhibitor levels [16]. Because immune suppression carries significant risks, such as serious infections or changes in blood counts, you will be monitored closely [19].

Once the bleeding stops and the inhibitors are eradicated, you will need ongoing laboratory surveillance [16]. Doctors will regularly monitor your factor VIII and inhibitor levels because relapses can occur. A recent review recommends maintaining this surveillance for at least two years after complete remission, though the exact schedule will be tailored to you [16].

Common questions in this guide

Can hemophilia A start for the first time in adulthood?
Yes. A rare condition called acquired hemophilia A can develop later in life when the immune system makes antibodies that block factor VIII. Mild inherited hemophilia can also go unnoticed until surgery, trauma, or another bleeding challenge.
What causes acquired hemophilia A, and does it mean I have cancer?
The immune system mistakenly produces antibodies that neutralize factor VIII. About half of cases have no identified cause; others are associated with autoimmune disease, pregnancy or recent childbirth, or certain cancers. An association does not mean you have cancer, but your clinician may recommend an evaluation based on your age and health.
What symptoms of acquired hemophilia A require emergency care?
Seek immediate emergency care for rapidly enlarging painful bruises, blood in urine or stool, vomiting or coughing blood, severe headache or confusion, severe back or abdominal pain, shortness of breath, or bleeding that will not stop. These symptoms can signal life-threatening internal bleeding.
How do doctors test for acquired hemophilia A?
A prolonged aPTT, a blood-clotting time test, can raise suspicion, especially when sudden bleeding occurs without a personal or family history of bleeding. Doctors confirm the diagnosis by measuring factor VIII activity, performing a mixing study, and testing for an inhibitor with an assay such as the Bethesda test. Other causes, including medication effects or mild inherited hemophilia, may also need evaluation.
How is acquired hemophilia A treated?
Treatment has two goals: control active bleeding and stop the immune system from making the factor VIII inhibitor. Doctors may use bypassing medicines or recombinant porcine factor VIII for bleeding, and corticosteroids, rituximab, or cyclophosphamide to suppress the immune response. A hematologist chooses the plan based on bleeding severity, inhibitor levels, age, health, and clotting risk.
Should I avoid aspirin and ibuprofen if acquired hemophilia A is suspected?
Do not take aspirin, ibuprofen, naproxen, or other nonsteroidal anti-inflammatory drugs unless your hematologist specifically tells you to, because they can increase bleeding risk. Avoid intramuscular injections when possible, tell healthcare professionals and dentists about the condition, and consider a medical alert bracelet.
Can acquired hemophilia A come back after treatment?
Yes, relapse can occur after the inhibitor is eradicated, so follow-up blood tests are important. Doctors monitor factor VIII activity and inhibitor levels, and surveillance may continue for at least two years after complete remission, with the schedule tailored to the patient.

Get notified when new evidence is published on Hemophilia A.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.

References

References (19)
  1. 1

    Acquired Hemophilia A After SARS-CoV-2 Infection: A Case Report.

    Nardella J, Comitangelo D, Marino R, et al.

    Journal of medical cases 2022; (13(5)):197-201 doi:10.14740/jmc3921.

    PMID: 35655623
  2. 2

    Acquired Hemophilia A: A Case Report.

    Shen M, Wang S, Sessa J, et al.

    Journal of pharmacy practice 2020; (33(4)):562-566 doi:10.1177/0897190019826474.

    PMID: 30727803
  3. 3

    Acquired Hemophilia A: Rare Cause of Upper Airway Hematoma and a Literature Review.

    Lim CC, Ling SW, Vijayan KV, et al.

    Indian journal of otolaryngology and head and neck surgery : official publication of the Association of Otolaryngologists of India 2023; (75(4)):3886-3888 doi:10.1007/s12070-023-03943-7.

    PMID: 37974717
  4. 4

    International recommendations on the diagnosis and treatment of acquired hemophilia A.

    Tiede A, Collins P, Knoebl P, et al.

    Haematologica 2020; (105(7)):1791-1801 doi:10.3324/haematol.2019.230771.

    PMID: 32381574
  5. 5

    Anesthetic management of patient with hemophilia a undergoing emergency ventriculoperitoneal shunting: A case report and review of literature.

    Khokhar RS, Hussain A, Khan MU, et al.

    Saudi journal of anaesthesia 2016; (10(4)):474-476 doi:10.4103/1658-354X.179120.

    PMID: 27833501
  6. 6

    Emicizumab in acquired hemophilia A: pros and cons of a new approach to the prevention and treatment of bleeding.

    Pasca S, Zanon E, Mannucci PM, Peyvandi F

    Blood transfusion = Trasfusione del sangue 2023; (21(6)):549-556 doi:10.2450/2023.0247-22.

    PMID: 36795341
  7. 7

    [PREGNANCY RELATED ACQUIRED HEMOPHILIA A].

    Dally N, Kashlikov M

    Harefuah 2019; (158(3)):184-186.

    PMID: 30916507
  8. 8

    Management of acquired hemophilia A: Review of current evidence.

    Charlebois J, Rivard GÉ, St-Louis J

    Transfusion and apheresis science : official journal of the World Apheresis Association : official journal of the European Society for Haemapheresis 2018; (57(6)):717-720 doi:10.1016/j.transci.2018.10.011.

    PMID: 30396835
  9. 9

    Acquired Hemophilia A.

    Pai M

    Hematology/oncology clinics of North America 2021; (35(6)):1131-1142 doi:10.1016/j.hoc.2021.07.007.

    PMID: 34535289
  10. 10

    Acquired hemophilia A and plasma cell neoplasms: a case report and review of the literature.

    Jalowiec KA, Andres M, Taleghani BM, et al.

    Journal of medical case reports 2020; (14(1)):206 doi:10.1186/s13256-020-02505-7.

    PMID: 33121522
  11. 11

    [Acquired hemophilia A].

    Amano K

    [Rinsho ketsueki] The Japanese journal of clinical hematology 2018; (59(6)):756-763 doi:10.11406/rinketsu.59.756.

    PMID: 29973457
  12. 12

    Spontaneous Hemarthrosis and Compartment Syndrome in an Elderly Female With Acquired Hemophilia A: A Case Report.

    Alam MS, Khan M, Lazarescu R

    Cureus 2025; (17(10)):e95170 doi:10.7759/cureus.95170.

    PMID: 41281120
  13. 13

    A Rare Case of Hemophilia: Acquired Factor VIII Deficiency.

    Winn SP, Mohsin F, Peeke S

    Cureus 2024; (16(6)):e62407 doi:10.7759/cureus.62407.

    PMID: 39011224
  14. 14

    Case Report: Acquired hemophilia A presenting with recurrent arthritis-like joint swelling and musculoskeletal hematomas-a focused literature review.

    Zhang J, Zhang L, Li SG, et al.

    Frontiers in medicine 2026; (13()):1964024 doi:10.3389/fmed.2026.1964024.

    PMID: 42876645
  15. 15

    Effectiveness of plasma exchange for acquired type A hemophilia.

    Goto S, Ookawara S, Ueda Y, et al.

    CEN case reports 2015; (4(2)):196-199 doi:10.1007/s13730-015-0168-z.

    PMID: 28509101
  16. 16

    Acquired hemophilia A: an illustrated review based on the French National Guidelines.

    Guillet B, d'Oiron R, Lacroix-Desmazes S, et al.

    Research and practice in thrombosis and haemostasis 2026; (10(5)):106820 doi:10.1016/j.rpth.2026.106820.

    PMID: 42657325
  17. 17

    Mixing Test in a Case of Combined Acquired Hemophilia A and Coagulation Factor Deficiency: A Case Report.

    Imataki O, Takahata K, Mukai Y, et al.

    Cureus 2025; (17(11)):e97307 doi:10.7759/cureus.97307.

    PMID: 41426902
  18. 18

    Laboratory coagulation tests and recombinant porcine factor VIII: A United Kingdom Haemophilia Centre Doctors' Organisation guideline.

    Bowyer A, Gray E, Lowe A, et al.

    Haemophilia : the official journal of the World Federation of Hemophilia 2022; (28(3)):515-519 doi:10.1111/hae.14536.

    PMID: 35279922
  19. 19

    Successful hemodialysis initiation in acquired hemophilia a managed with susoctocog alfa and emicizumab.

    Kihara A, Tamaki M, Sumitani R, et al.

    CEN case reports 2025; (15(1)):7 doi:10.1007/s13730-025-01036-8.

    PMID: 41436689

This page is for informational purposes only and does not constitute medical advice. Suspected acquired hemophilia A or bleeding that will not stop requires immediate emergency care; a hematologist should interpret your tests and guide treatment.